论文部分内容阅读
[目的]研究归脾汤联合质子泵抑制剂三联疗法治疗消化性溃疡(PU)的远期疗效。[方法]将90例PU患者随机分为2组,治疗组45例应用归脾汤联合质子泵抑制剂三联疗法(奥美拉唑、阿莫西林及枸缘酸铋钾)治疗;对照组45例,应用质子泵抑制剂三联疗法治疗。[结果]治疗组临床总有效率95.6%,胃镜1年内复发率7.5%,胃镜2年内复发率12.5%,与对照组比较差异有统计学意义(P<0.05)。[结论]归脾汤联合质子泵抑制剂三联疗法治疗PU,有助于提高愈合率及降低复发率,巩固远期疗效。
[Objective] To study the long-term efficacy of Guipi Decoction combined with proton pump inhibitor triple therapy in the treatment of peptic ulcer (PU). [Method] Ninety patients with PU were randomly divided into two groups. The treatment group was treated with Guipi Decoction combined with proton pump inhibitor triple therapy (omeprazole, amoxicillin and bismuth potassium citrate), and the control group 45 Example, the application of proton pump inhibitor triple therapy. [Results] The total effective rate of the treatment group was 95.6%, the recurrence rate of the gastroscope within one year was 7.5%, and the recurrence rate of the gastroscope within 12.5 years was 12.5%, which was significantly different from the control group (P <0.05). [Conclusion] Guipi Decoction combined with proton pump inhibitor triple therapy can improve the healing rate, reduce the recurrence rate and consolidate the long-term efficacy.